Walleye Trading’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.8K Sell
7,300
-2,200
-23% -$24.1K ﹤0.01% 3622
2025
Q4
$107K Buy
9,500
+3,300
+53% +$40.9K ﹤0.01% 3704
2025
Q3
$93.1K Buy
6,200
+4,300
+226% +$62.6K ﹤0.01% 3738
2025
Q2
$26.8K Buy
+1,900
New +$33.9K ﹤0.01% 3925
2024
Q1
Sell
-2,200
Closed -$94.2K 4773
2023
Q4
$94.2K Sell
2,200
-162,900
-99% -$5.07M ﹤0.01% 4167
2023
Q3
$4.29M Buy
165,100
+5,800
+4% +$121K 0.01% 1221
2023
Q2
$3.81M Hold
159,300
0.01% 1166
2023
Q1
$2.18M Sell
159,300
-7,800
-5% -$124K ﹤0.01% 1613
2022
Q4
$2.32M Buy
+167,100
New +$2.36M 0.01% 1570

Other funds holding BHVN

Walleye Trading's BHVN Position: Q1 2026 in Review

Walleye Trading reduced its Biohaven (BHVN) stake by 69% in Q1 2026, selling an estimated $103K and leaving 4,153 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3761.

Walleye Trading first reported a position in BHVN in Q1 2023 and has held it in 7 quarters since. The position peaked at $872K in Q2 2023. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Walleye Trading held 4,153 shares of Biohaven worth $35.1K as of Q1 2026.
  • Walleye Trading sold 9,400 Biohaven shares in Q1 2026, an estimated $103K.
  • Biohaven made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3761 holding.
  • Walleye Trading first reported a position in Biohaven in Q1 2023 and has held it in 7 quarters since.
  • Walleye Trading's Biohaven position peaked at $872K in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.